Sumatriptan Tablet
Product Images NDC 16714-796

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 16714-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line chart depicting the estimated probability of response over time in minutes from the initial dose for Sumatriptan tablets at 25 mg, 50 mg, and 100 mg doses compared to placebo. The chart shows dose-dependent response rates increasing over a 240-minute period post-dose.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph showing the estimated probability of remediating or rescue over time in hours from initial dose for Sumatriptan tablets in 25 mg, 50 mg, and 100 mg strengths compared to placebo. The graph illustrates increasing probabilities over a 24-hour period, with distinct curves for each dose and placebo.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 25 mg by NorthStar Rx LLC. The label specifies the product contains 9 unit-dose oral tablets, with each tablet containing 35 mg sumatriptan succinate USP equivalent to 25 mg sumatriptan. The label includes usage instructions, storage conditions, manufacturer information, and an illustration demonstrating how to separate the blister tablets.*

FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 50 mg oral tablets by NorthStar Rx LLC. The label indicates 9 unit-dose tablets per package, containing 70 mg sumatriptan succinate equivalent to 50 mg sumatriptan. It includes storage instructions, manufacturer information (Aurobindo Pharma Limited, India), and illustrated instructions for tablet removal from blister packs.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 100 mg oral tablets by NorthStar Rx LLC. The label indicates 9 unit-dose tablets per package. It provides dosage information, storage instructions, and manufacturing details, including production in India by Aurobindo Pharma Limited. The label also features NDC 16714-798-01 and instructions for tablet removal from the blister pack.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate, showing the molecular components and bonds, including the indole ring and sulfonamide group characteristic of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.